OEL
Occupational Exposure Limits Database
Dehydroepiandrosterone sulfate sodium salt
脱氢表雄酮硫酸钠
,
5-雄甾烯-3Β-醇-17-酮硫酸钠盐
,
脱氢表雄甾酮-3-硫酸钠盐
,
硫酸普拉睾酮钠, Teloin, Sodium dehydroepiandrosterone sulfate, SODIUM PRASTERONR SULFATE, Androst-5-en-17-one, 3-(sulfooxy)-, sodium salt, (3β)- (1:1), Sodium (3β)-17-oxoandrost-5-en-3-yl sulfate, sodiumprasteronesulfate, (3b)-3-(Sulfooxy)androst-5-en-17-one Sodium Salt, Sodium dehydroepiandrosterone-3-sulfate, prasterone sulfate sodium salt, MFCD00010470, Dehydroepiandrosterone sulfate sodium salt, Sodium prasterone sulfate, EINECS 214-152-2, sodiumdehydroepiandrosteronesulfate, dha-s, Prasterone sulfate sodium, Dehydroepiandrosterone sulfate sodium, Astenile, PRASTERONE SODIUM SULFATE, 3b-Hydroxy-5-androsten-17-one Sodium Sulfate, 3b-Hydroxyandrost-5-en-17-one Hydrogen Sulfate Sodium Salt, prasterone sodium sulphate, Dehydroepiandrosterone-3-sulfate sodium salt, Mylis
CAS Number: 1099-87-2
IUPAC name: sodium [(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] sulfate
Molecular formula: C19H27NaO5S
Molecular weight: 390.469
InChI: InChI=1S/C19H28O5S.Na/c1-18-9-7-13(24-25(21,22)23)11-12(18)3-4-14-15-5-6-17(20)19(15,2)10-8-16(14)18;/h3,13-16H,4-11H2,1-2H3,(H,21,22,23);/q;+1/p-1/t13-,14-,15-,16-,18-,19-;/m0./s1
InChIKey: GFJWACFSUSFUOG-ZJTJBYBXSA-M
SMILES: C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CC[C@@H](C4)OS(=O)(=O)[O-])C.[Na+]
EINECS: -
One-Click Alert
Export ReportRegions
Filter All
Category
Filter All
Sort
By key inventories
By listed
Focused on chemical complianceEmpowering the entire lifecycle of the chemical industry
Substance Information
CAS Number:
1099-87-2
Chemical Name:
Sodium (3β)-androst-5-en-17-one 3-sulphate
Chinese name:
Date of inquiry :
Apr 28, 2026
Inquiry website:
https://www.chemradar.com/en/tools/oelOEL occupational exposure limit compliance inquiry report
| Inventory Name | Country/Region | Status | Obligations |
|---|
ChemRadar
Global chemical compliance information, data and technical service platform
Service Hotline: +353 1 477 3710 (EU) +86 571 8720 6598 (CN) +81 70 9365 8022 (JP) +82 2 6347 8816 (KR)
Disclaimer
1.
CIRS aims to keep the content of this site accurate and up to date. However, CIRS makes no warranties or representations regarding the quality, accuracy, completeness or reliability of information on the site.
2.
In no event shall CIRS assume or have any responsibility or liability for any information on this site or for any claims, damages or losses resulting from their use.
3.
CIRS reserves the right, at our discretion, to change, modify, add to, or remove portions of information on this site at any time without notice.
